In addition to modulating the tumor microenvironment and cell metabolism, S100A8/S100A9 enhances chemoresistance of breast cancer cells by activating pro-survival ERK1, ERK2 and ribosomal protein S6 kinas β1 pathways (69). Here, MAPK1 is linked to breast cancer.